CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) [NA]

Feasibility study for enhanced MRI in early-stage non-small cell lung cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Dana-Farber Cancer Institute | Conditions: Non Small Cell Lung Cancer | NA | Status: TERMINATED | Results posted: 2021-10-12